Syndromic multisystem autoimmune disease due to Itch deficiency

Syndromic multisystem autoimmune disease due to Itch deficiency (also known as ITCH deficiency or autoimmune disease, multisystem, with facial dysmorphism) is an extremely rare autosomal recessive disorder caused by biallelic loss-of-function mutations in the ITCH gene (also known as AIP4), which encodes an E3 ubiquitin ligase involved in immune regulation. The ITCH protein plays a critical role in controlling immune cell signaling pathways, and its deficiency leads to unchecked immune activation and multisystem autoimmunity. The disease typically presents in early childhood and is characterized by failure to thrive, hepatosplenomegaly, multisystem autoimmune manifestations including autoimmune hepatitis, autoimmune enteropathy, and thyroid disease. Affected individuals may also exhibit chronic lung disease, developmental delay, and distinctive facial features (relative macrocephaly, broad nasal bridge, and widely spaced eyes). Immunological abnormalities include elevated immunoglobulin levels and the presence of various autoantibodies. The condition was first described in Old Order Amish families. Treatment is primarily supportive and directed at managing the autoimmune complications. Immunosuppressive therapies may be employed to control autoimmune manifestations, though there is no established curative treatment. Given the rarity of the condition, management is largely guided by expert opinion and individual clinical response. Long-term prognosis depends on the severity and extent of organ involvement.

Common questions about Syndromic multisystem autoimmune disease due to Itch deficiency